The Application and Challenges of Artificial Intelligence in G Protein-Coupled Receptor Drug Virtual Screening
DOI:
https://doi.org/10.61173/q2f3vy73Keywords:
Artificial Intelligence, Deep Learning, G Protein-Coupled Receptor, Virtual Screening, Drug DiscoveryAbstract
G protein-coupled receptors play important roles in various diseases and are key targets for drug discovery. Virtual screening has traditionally been used to identify potential drug candidates from large compound libraries but faces challenges in computational resources and time constraints. The integration of artificial intelligence technologies has improved screening precision and reduced costs. This review discusses current developments, challenges, and future directions in leveraging artificial intelligence to advance GPCR drug screening.